Comparative study on the effect of aspirin, TP receptor antagonist and TxA 2 synthase inhibitor on the vascular tone of human saphenous vein and internal mammary artery.
Autor: | Ozen G; Department of Pharmacology, Faculty of Pharmacy, Istanbul University, Istanbul, Turkey. Electronic address: gulsevozen@istanbul.edu.tr., Aljesri K; Department of Pharmacology, Faculty of Pharmacy, Istanbul University, Istanbul, Turkey., Abdelazeem H; Université de Paris, INSERM, UMR-S 1148, CHU X. Bichat, 75018 Paris, France; Université Sorbonne Paris Nord, 93430 Villetaneuse, France; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Alexandria University, Egypt., Norel X; Université de Paris, INSERM, UMR-S 1148, CHU X. Bichat, 75018 Paris, France; Université Sorbonne Paris Nord, 93430 Villetaneuse, France., Turkyılmaz G; Department of Cardiovascular Surgery, Bakirkoy Dr Sadi Konuk Education and Research Hospital Bakırkoy, Istanbul, Turkey., Turkyılmaz S; Department of Cardiovascular Surgery, Bakirkoy Dr Sadi Konuk Education and Research Hospital Bakırkoy, Istanbul, Turkey., Topal G; Department of Pharmacology, Faculty of Pharmacy, Istanbul University, Istanbul, Turkey. |
---|---|
Jazyk: | angličtina |
Zdroj: | Life sciences [Life Sci] 2021 Dec 01; Vol. 286, pp. 120073. Date of Electronic Publication: 2021 Oct 21. |
DOI: | 10.1016/j.lfs.2021.120073 |
Abstrakt: | Aims: Thromboxane (TxA Main Methods: Using isolated organ bath, saphenous vein and internal mammary artery preparations were incubated with TP receptor antagonist, TxS inhibitor, aspirin, IP or EP4 receptor antagonist. Then prostaglandin (PG)E Key Findings: TP receptor antagonist inhibited the contraction induced by PGE Significance: TP receptor antagonist and TxS inhibitor are more effective to reduce contraction induced by different spasmogens in comparison to aspirin. Our results suggest that TP receptor antagonist and TxS inhibitor might have an advantage over aspirin due to their preventive effect on increased vascular reactivity observed in post-operative period of coronary artery bypass grafting. (Copyright © 2021 Elsevier Inc. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |